Recall Z-2452-2021— Cellex
Class II · Ongoing
Class II FDA medical device recall by Cellex, initiated 2021-03-01. FDA's recall record names no specific 510(k) clearance for this event. Product: Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue". Reason: The kit does not have an emergency use authorization (EUA)..
- Recalling firm
- Cellex
- Classification
- Class II
- Status
- Ongoing
- Initiated
- 2021-03-01
- Firm location
- Morrisville, NC, United States
Product description
Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue"
Reason for recall
The kit does not have an emergency use authorization (EUA).
Data sourced from openFDA. This site is unofficial and independent of the FDA.